Where Global Innovation
and Capital Meet
Sectors Art of CVCConsumerEnergyFinancialHealthIndustrialITMediaServicesStartupsTelecomsTransportUniversity

Global University Venturing

Daily deal net: October 28, 2020

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.


Oct 28, 2020

Floadia floats to series C funding

Miyako Capital has participated in the second close of an $11.4m round Floadia, whose investors already include Innovations and Future Creation.

Oct 28, 2020

OSI appoints Alexis Dormandy as CEO

Alexis Dormandy will join Oxford Sciences Innovation as chief executive, moving over from Atomico by January 2021 to take over from interim CEO Jim Wilkinson.

Oct 28, 2020

Waldo locates Arkansas role

Arkansas has lured Weston Waldo, an innovation professional with expertise at I-Corps, to run its venture development programming.

Oct 28, 2020

HBCUs gain $10.7m venture fund

HBCU Seed will invest in eligible startups from US historically black colleges and universities at a time of heightened tension over racial inequalities.

Oct 28, 2020

The Engine shifts into $230m second fund

MIT has put $35m into The Engine's second fund – up from its $25m commitment to the first fund – and has been joined by Harvard as a new LP.

Oct 28, 2020

The future of work: a roundtable discussion

A panel of thought leaders spanning academia and industry discusses the path forward for tech transfer at the Digital Forum 2.0

Oct 28, 2020

Uniseed: the first 20 years

September 2020 marked 20 years since the formation of multi-university venture fund Uniseed. To still be operating after 20 years is quite an achievement, given the difficulty of commercialising early-stage research.

Oct 28, 2020

OSI gets out from Base Genomics

Exact Sciences has shelled out $410m to buy University of Oxford early cancer test company Base Genomics, incorporated in July 2019.

Oct 28, 2020

Thrive Earlier Detection scores $2.15bn exit

Exact Sciences is set to acquire Johns Hopkins spinout Thrive Earlier Detection for up to $2.15bn in cash and stock, including $1.7bn upfront.

Oct 28, 2020

Does Deerfield have The Cure?

Deerfield Management is putting up $2bn for early-stage life sciences research through to 2030, but what does its involvement mean for its partner universities?

Oct 28, 2020
© 2025 Mawsonia Ltd. All rights reserved.
test reg

Login

Not yet subscribed?

See your subscription offers here